Prices delayed by at least 15 minutes | Print
Haleon PLC (HLN)
ORD GBP0.01Open
369.50p
Previous close
369.80p
Trade high
369.60p
Volume
19,990,276
Year high
416.10p
Year low
274.40p
Dividend yield
1.97%
Market capitalisation
£32.51 bn
P/E ratio
20.43
ISIN
GB00BMX86B70
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 10/04/2026 | 14/08/2026 |
| Ex-dividend date | 09/04/2026 | 13/08/2026 |
| Payment date | 14/05/2026 | 17/09/2026 |
| Amount | 4.90p | 2.40p |
Company profile
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of salesfrom global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 25/08/2026 | 04:54:38 | 369.6 | 2,073 | 7,661.81 |
| 25/08/2026 | 04:36:30 | 369.6 | 69,085 | 255,338.16 |
| 25/08/2026 | 04:35:05 | 369.6 | 5,290,006 | 19,551,862.18 |
| 25/08/2026 | 04:29:59 | 369.1 | 6 | 22.15 |
| 25/08/2026 | 04:29:59 | 369.1 | 43 | 158.71 |